TP53 and neoplasm: In over half of all human cancers, the TP53 gene presents missense mutations that destroy the tumor suppressive competency of the protein and confer new oncogenic capacities (gain-of-function (GOF) mutations) that give a growth advantage to the tumor cell [4,5,6].